Latest Manufacturing News

Ansell Limited reported robust FY25 results, driven by strong organic growth and the successful integration of Kimberly-Clark’s PPE business. The company also advanced its sustainability commitments and navigated tariff challenges with strategic pricing and sourcing.

thl reports a statutory net loss for FY25, driven by impairments, while underlying profit falls 45%. The company maintains dividends and outlines strategic initiatives to restore growth and profitability.

Tourism Holdings Limited reported a statutory net loss in FY25 amid challenging market conditions but remains confident in a strategic turnaround targeting over $100 million in annualised NPAT within four years.

RLF AgTech Ltd has secured $4.5 million through a discounted share placement to support its strategic growth initiatives following a robust 74% revenue increase in FY2025. The company is advancing its Australian relaunch, expanding manufacturing, and entering new Asian markets.

RLF AgTech has successfully raised $4.5 million through a heavily oversubscribed placement, aiming to accelerate its Australian expansion and reduce leverage by cancelling convertible notes.

Carbonxt Group Limited has announced a fully underwritten non-renounceable entitlement offer of Loyalty Options to eligible shareholders, aiming to raise approximately $697,772 to support its new Activated Carbon manufacturing facility in Kentucky. The offer provides shareholders with one Loyalty Option for every six shares held, exercisable at $0.07 within three years.

Carbonxt Group Limited has launched a fully underwritten $0.7 million Loyalty Options entitlement offer to existing shareholders, aiming to support working capital and operational growth following its new Kentucky facility commissioning.

NOVONIX Limited reports progress scaling its Chattanooga synthetic graphite plant, secures major funding, and benefits from U.S. tariffs on Chinese imports, while narrowing its half-year loss.

LTR Pharma has announced that its erectile dysfunction treatment SPONTAN now boasts an 18-month shelf life, surpassing commercial standards and paving the way for international market growth.

Cobram Estate Olives Limited (ASX – CBO) delivered a record FY2025 with a 167.8% surge in net profit and doubled US branded sales, underpinning its growth strategy and sustainability commitments.

Electro Optic Systems reveals a challenging half-year with a steep revenue drop and loss from continuing operations, offset by a substantial gain from divesting EM Solutions and a major new laser weapons contract.

Arovella Therapeutics reported a 14% reduction in net loss to $7.5 million for FY25, bolstered by a $15 million capital raise to fund its lead iNKT cell therapy program progressing toward a pivotal phase 1 clinical trial.